Last Updated: 21/11/2023

Design of plasma Pepsin IX and X inhibitors for malaria drug development

Objectives

This project aim at design of plasma Pepsin IX and X inhibitors for malaria drug development.

Principal Institution

Latvian Institute of Organic Synthesis (OSI)

Principal Investigators / Focal Persons

Raitis Bobrovs

External reference

Project details

Themes

Drug-based Strategies
Product Development

Date

Sep 2019 — Sep 2022

Funding Details
Ministry of Education and Science (MoES) Latvia, Latvia

Grant ID: 1.1.1.2/VIAA/2/18/379
Country / Project Site(s)

Latvia

SHARE

Related Resources

Drug Design for Global Health
Drug Design for Global Health
Paediatric drug optimization for malaria: meeting report, 24-26 June 2025
Paediatric drug optimization for malaria: meeting report, 24-26 June 2025
Introduction to Small Molecule Drug Discovery & Development
Introduction to Small Molecule Drug Discovery & Development

Related Projects

Oct 2023 —
Sep 2025
Design and development of dual inhibitors of Plasmodium falciparum PI4K and PKG as lead compound candidates for Malaria
Nov 2024 —
Sep 2029
MMV: Drug Discovery, Translation, Development & Access 2024-2030
Jul 2023 —
Jul 2027
Structure-guided development of potent PfPKG inhibitors for malaria chemoprotection
SHARE